Cerebras Stock Tumbles on Short-Seller Report and Share Lockup Expiration

Shares of AI chipmaker Cerebras Systems (CBRS) fell more than 4% in Wednesday trading after short-seller Culper Research disclosed a short position and published a report challenging the company's core technology. The decline was intensified by the expiration of a post-IPO lockup period, which released a significant number of shares into the market.

Culper Research Challenges Technology Lifespan

The report from Culper Research alleges that Cerebras's flagship wafer-scale engines have an effective field lifespan of only 1.5 to 2.5 years. According to the short-seller, such a short operational life would materially undermine the long-term economics of the company's business model.

Culper's report also disputes claims by Cerebras CEO Andrew Feldman regarding a proprietary connector material developed to manage thermal expansion. The short-seller alleges the company uses a decades-old, commercially available material called PariPoser. Furthermore, the report claims Cerebras runs continuous background operations on its hardware to prevent it from cooling down, citing a purported admission from a company architect at an industry event.

Share Lockup Adds to Selling Pressure

Ad

Adding to the negative sentiment, Wednesday marked the expiration of a post-IPO lockup agreement, unlocking approximately 19.4 million shares for trading. Such events can create a supply overhang, as early investors and insiders become eligible to sell their holdings, putting downward pressure on the stock price.

The stock's decline appeared to be company-specific, as the broader market provided little drag. The Nasdaq Composite was nearly flat, while the S&P 500 was slightly positive, indicating that the sell-off was not driven by a wider market or sector trend. During the session, Cerebras shares were trading near the low end of their daily range.

Reversal of Recent Gains

Wednesday's drop reverses a sharp rally from the previous session. Cerebras stock had surged on Tuesday following the announcement of a partnership with Oracle, which will make the company's AI inference technology available on Oracle Cloud Infrastructure starting in 2027. That deal was widely interpreted by investors as a significant validation of Cerebras's commercial momentum, but the combined impact of the short report and share unlock has overshadowed the positive news.